Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1945 1
1949 2
1951 2
1952 1
1953 1
1954 2
1955 1
1956 1
1957 1
1958 4
1959 4
1960 8
1961 8
1962 14
1963 12
1964 17
1965 17
1966 11
1967 10
1968 14
1969 18
1970 23
1971 30
1972 23
1973 29
1974 24
1975 29
1976 36
1977 32
1978 32
1979 26
1980 29
1981 28
1982 28
1983 29
1984 43
1985 26
1986 42
1987 38
1988 31
1989 25
1990 29
1991 22
1992 22
1993 27
1994 22
1995 19
1996 14
1997 7
1998 13
1999 27
2000 17
2001 19
2002 14
2003 24
2004 22
2005 20
2006 17
2007 14
2008 17
2009 16
2010 11
2011 21
2012 12
2013 12
2014 14
2015 22
2016 35
2017 31
2018 31
2019 24
2020 27
2021 30
2022 17
Text availability
Article attribute
Article type
Publication date

Search Results

1,385 results
Results by year
Filters applied: . Clear all
Page 1
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, Gaipl US, Gameiro SR, Garg AD, Golden E, Han J, Harrington KJ, Hemminki A, Hodge JW, Hossain DMS, Illidge T, Karin M, Kaufman HL, Kepp O, Kroemer G, Lasarte JJ, Loi S, Lotze MT, Manic G, Merghoub T, Melcher AA, Mossman KL, Prosper F, Rekdal Ø, Rescigno M, Riganti C, Sistigu A, Smyth MJ, Spisek R, Stagg J, Strauss BE, Tang D, Tatsuno K, van Gool SW, Vandenabeele P, Yamazaki T, Zamarin D, Zitvogel L, Cesano A, Marincola FM. Galluzzi L, et al. Among authors: kaufman hl. J Immunother Cancer. 2020 Mar;8(1):e000337. doi: 10.1136/jitc-2019-000337. J Immunother Cancer. 2020. PMID: 32209603 Free PMC article. Review.
Oncolytic viruses: a new class of immunotherapy drugs.
Kaufman HL, Kohlhapp FJ, Zloza A. Kaufman HL, et al. Nat Rev Drug Discov. 2015 Sep;14(9):642-62. doi: 10.1038/nrd4663. Nat Rev Drug Discov. 2015. PMID: 26323545 Free PMC article. Review.
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
Puzanov I, Diab A, Abdallah K, Bingham CO 3rd, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS; Society for Immunotherapy of Cancer Toxicity Management Working Group. Puzanov I, et al. Among authors: kaufman hl. J Immunother Cancer. 2017 Nov 21;5(1):95. doi: 10.1186/s40425-017-0300-z. J Immunother Cancer. 2017. PMID: 29162153 Free PMC article.
Immunotherapy for Non-melanoma Skin Cancer.
Shalhout SZ, Emerick KS, Kaufman HL, Miller DM. Shalhout SZ, et al. Among authors: kaufman hl. Curr Oncol Rep. 2021 Aug 27;23(11):125. doi: 10.1007/s11912-021-01120-z. Curr Oncol Rep. 2021. PMID: 34448958 Free PMC article. Review.
Clinical landscape of oncolytic virus research in 2020.
Macedo N, Miller DM, Haq R, Kaufman HL. Macedo N, et al. Among authors: kaufman hl. J Immunother Cancer. 2020 Oct;8(2):e001486. doi: 10.1136/jitc-2020-001486. J Immunother Cancer. 2020. PMID: 33046622 Free PMC article. Review.
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, Milhem M, Cranmer L, Curti B, Lewis K, Ross M, Guthrie T, Linette GP, Daniels GA, Harrington K, Middleton MR, Miller WH Jr, Zager JS, Ye Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS. Andtbacka RH, et al. Among authors: kaufman hl. J Clin Oncol. 2015 Sep 1;33(25):2780-8. doi: 10.1200/JCO.2014.58.3377. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014293 Clinical Trial.
1,385 results